Hims & Hers Health, Inc. (HIMS) Price CAGR:-47.91%(TTM)
The price cagr for Hims & Hers Health, Inc. (HIMS) is -47.91% over the latest trailing 12-month period. The comparable SPY value is +20.75%. Year-to-date price return is -13.83%. Price CAGR uses adjusted close price history and excludes dividends.
The price CAGR for Hims & Hers Health, Inc. (HIMS) stock is -47.91% over the past 12 months. The 3 year CAGR is 47.28% and the 5 year CAGR is 17.51%. The price CAGR (Compound Annual Growth Rate) shows how Hims & Hers Health, Inc.'s stock price has grown over various time periods. This measures pure price appreciation without including dividends.
HIMS Price CAGR Chart
Hims & Hers Health, Inc. (HIMS)
HIMS Quarterly Price (YoY)
Price growth vs the same quarter one year earlier, last 20 quarters.
HIMS Price CAGR History
| Year | Start Price | End Price | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | 16.10 | 57.82 | +41.72 | +259.13% | +259.13% |
| 2024 | 6.31 | 16.10 | +9.79 | +155.15% | +155.15% |
| 2023 | 6.14 | 6.31 | +0.17 | +2.77% | +2.77% |
| 2022 | 8.66 | 6.14 | -2.52 | -29.10% | -29.10% |
| 2021 | 11.00 | 8.66 | -2.34 | -21.27% | -21.27% |
| 2020 | 9.80 | 11.00 | +1.20 | +12.24% | +12.24% |
Quarterly Price: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q2 2026 | 29 | +38.7% | -41.7% |
| Q1 2026 | 21 | -37.2% | -28.8% |
| Q4 2025 | 33 | -44.1% | +31.3% |
| Q3 2025 | 59 | +19.7% | +232.7% |
| Q2 2025 | 49 | +69.6% | +146.8% |
| Q1 2025 | 29 | +15.8% | +88.4% |
| Q4 2024 | 25 | +41.6% | +178.7% |
| Q3 2024 | 18 | -11.2% | +182.5% |
| Q2 2024 | 20 | +29.4% | +120.2% |
| Q1 2024 | 15 | +71.3% | +56.1% |
| Q4 2023 | 9 | +43.6% | +41.5% |
| Q3 2023 | 6 | -30.8% | +12.7% |
| Q2 2023 | 9 | -8.3% | +100.7% |
| Q1 2023 | 10 | +55.3% | +85.9% |
| Q4 2022 | 6 | +14.3% | -2.6% |
| Q3 2022 | 6 | +23.2% | -26.0% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum